Identification of immunogenic epitopes is most accurately determined by mass-spectrometric (MS) analysis of peptides eluted from tumor surface from MHC, followed by empiric validation, and finally, by confirming that the MS-defined peptides elicit T cell recognition of the tumor. This evidence concerns the gene HLA-C and neoplasm.